Scott Andrew Jordan
Direktor/Vorstandsmitglied bei Stingray Therapeutics, Inc.
Profil
Scott Andrew Jordan is the founder of Healthiosxchange, which was founded in 2013.
He is currently a Director at Stingray Therapeutics, Inc. Mr. Jordan's former positions include Chief Financial Officer at Iterion Therapeutics, Inc. from 2016 to 2018, Vice President at Healthios Capital Markets LLC from 2010 to 2013, Chief Financial Officer at Salarius Pharmaceuticals LLC, and Chief Business Officer at Salarius Pharmaceuticals, Inc. from 2019 to 2020.
Mr. Jordan's education includes an undergraduate degree from Michigan State University and an MBA from Kellstadt Graduate School of Business.
Aktive Positionen von Scott Andrew Jordan
| Unternehmen | Position | Beginn |
|---|---|---|
Stingray Therapeutics, Inc.
 Stingray Therapeutics, Inc. BiotechnologyHealth Technology Stingray Therapeutics, Inc. specializes in identifying targets with untapped potential to modulate the tumor microenvironment. The company was founded by Jonathan P. Northrup and Sunil Sharma and is headquartered in Houston, TX. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Scott Andrew Jordan
| Unternehmen | Position | Ende |
|---|---|---|
| SALARIUS PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 13.09.2019 |
Iterion Therapeutics, Inc.
 Iterion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Iterion Therapeutics, Inc. provides pharmaceuticals services. The firm products are used in the treatment of colorectal, hematopoietic, and other targeted cancers. The company was founded by Jonathan P. Northrup in 2010 and is headquartered in Houston, TX. | Finanzdirektor/CFO | 01.08.2018 |
| Healthiosxchange | Gründer | 01.06.2016 |
Healthios Capital Markets LLC
 Healthios Capital Markets LLC Investment ManagersFinance Healthios Capital Markets LLC provides financial advisory services. The private company is based in Northbrook, IL and has subsidiaries in Thailand and Singapore. The company was founded by Fritz Reichenbach. | Corporate Officer/Principal | 01.03.2013 |
Salarius Pharmaceuticals LLC
 Salarius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Salarius Pharmaceuticals LLC manufactures drugs for cancer. It specializes in epigenetics, pipeline and LSD1 research, and development services. The company was founded by Jonathan P. Northrup and Sharma Sunil in 2014 and is headquartered in Houston, TX. | Finanzdirektor/CFO | - |
Ausbildung von Scott Andrew Jordan
| Michigan State University | Undergraduate Degree |
| Kellstadt Graduate School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SALARIUS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Iterion Therapeutics, Inc.
Iterion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Iterion Therapeutics, Inc. provides pharmaceuticals services. The firm products are used in the treatment of colorectal, hematopoietic, and other targeted cancers. The company was founded by Jonathan P. Northrup in 2010 and is headquartered in Houston, TX. | Health Technology |
Healthios Capital Markets LLC
Healthios Capital Markets LLC Investment ManagersFinance Healthios Capital Markets LLC provides financial advisory services. The private company is based in Northbrook, IL and has subsidiaries in Thailand and Singapore. The company was founded by Fritz Reichenbach. | Finance |
Salarius Pharmaceuticals LLC
Salarius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Salarius Pharmaceuticals LLC manufactures drugs for cancer. It specializes in epigenetics, pipeline and LSD1 research, and development services. The company was founded by Jonathan P. Northrup and Sharma Sunil in 2014 and is headquartered in Houston, TX. | Health Technology |
Stingray Therapeutics, Inc.
Stingray Therapeutics, Inc. BiotechnologyHealth Technology Stingray Therapeutics, Inc. specializes in identifying targets with untapped potential to modulate the tumor microenvironment. The company was founded by Jonathan P. Northrup and Sunil Sharma and is headquartered in Houston, TX. | Health Technology |
| Healthiosxchange |
